Editing
AUA: Overactive Bladder (2019)
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===== Physical exam (4) ===== # '''<span style="color:#ff0000">Abdominal exam</span>''' #*Assess for scars, masses, hernias and areas of tenderness as well as for suprapubic distension that may indicate urinary retention # '''<span style="color:#ff0000">Rectal/genitourinary exam</span>''' #*'''To rule out''' #**'''Pelvic floor disorders (e.g., pelvic floor muscle spasticity, pain, pelvic organ prolapse) in females''' #**'''Prostatic pathology in males''' #*'''In menopausal females, atrophic vaginitis should be assessed''' as a possible contributing factor to incontinence symptoms. #*'''Assess for perineal skin for rash or breakdown.''' #*'''Assess perineal sensation, rectal sphincter tone and ability to contract the anal sphincter''' to #**Evaluate pelvic floor tone and potential ability to perform pelvic floor exercises (e.g., the ability to contract the levator ani muscles) #**Rule out impaction and constipation. # '''<span style="color:#ff0000">Assessment of lower extremities for edema</span>''' #*To assess for the potential for fluid shifts during periods of postural changes #'''<span style="color:#ff0000">Patient’s attire and ability to dress independently</span>''' (as a surrogate for cognitive function) #*The ability of the patient to dress independently is informative of sufficient motor skills related to toileting habits. This can provide information on the cognitive function of the patient, which is important to evaluate when considering anticholinergics. #*A Mini-Mental State Examination (MMSE) should be conducted on all patients who may be at risk for cognitive impairment to determine whether symptoms are aggravated by cognitive problems, to ensure that they will be able to follow directions for behavioral therapy and/or to determine the degree of risk for cognitive decline with anti-muscarinic therapy.
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information